Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard B Weiner

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Pediatrics|September 3, 2002
Head liceBarbara L Frankowski, Leonard B Weiner,
The Pediatric Infectious Disease Journal|June 25, 2015
Re-evaluating the New Committee on Infectious Diseases Recommendations for Palivizumab Use in Premature InfantsRam Yogev, Leonard R Krilov, Jaime E Fergie, et al.
Human Vaccines & Immunotherapeutics|February 19, 2016
Evaluation of recent New Vaccine Surveillance Network data regarding respiratory syncytial virus hospitalization rates in US preterm infantsJohn P DeVincenzo, Christopher S Ambrose, Doris Makari, et al.
Journal of Medical Economics|March 23, 2012
Cost-effectiveness analysis of palivizumab among pre-term infant populations covered by Medicaid in the United StatesLeonard B Weiner, Anthony S Masaquel, Mark J Polak, et al.
Journal of Medical Economics|May 12, 2012
Cost utility of palivizumab prophylaxis among pre-term infants in the United States: a national policy perspectiveParthiv J Mahadevia, Anthony S Masaquel, Mark J Polak, et al.
Clinical Pediatrics|April 22, 2008
Dipylidium caninum mimicking recurrent enterobius vermicularis (pinworm) infectionAyman Samkari, Deanna L Kiska, Scott W Riddell, et al.
The Journal of Pediatrics|December 17, 2009
Incidence of invasive community-onset Staphylococcus aureus infections in children in Central New YorkManika Suryadevara, Maria R Moro, Paula F Rosenbaum, et al.
BMC Pediatrics|October 14, 2014
Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysisLeonard R Krilov, Anthony S Masaquel, Leonard B Weiner, et al.
Pediatrics|December 2, 2009
The 2009 COID recommendations for RSV prophylaxis: issues of efficacy, cost, and evidence-based medicineLeonard R Krilov, Leonard B Weiner, Ram Yogev, et al.
Vaccine|May 25, 2017
Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infantsNicola P Klein, Remon Abu-Elyazeed, Matthew Cornish, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Pediatrics|September 3, 2002
Head liceBarbara L Frankowski, Leonard B Weiner,
The Pediatric Infectious Disease Journal|June 25, 2015
Re-evaluating the New Committee on Infectious Diseases Recommendations for Palivizumab Use in Premature InfantsRam Yogev, Leonard R Krilov, Jaime E Fergie, et al.
Human Vaccines & Immunotherapeutics|February 19, 2016
Evaluation of recent New Vaccine Surveillance Network data regarding respiratory syncytial virus hospitalization rates in US preterm infantsJohn P DeVincenzo, Christopher S Ambrose, Doris Makari, et al.
Journal of Medical Economics|March 23, 2012
Cost-effectiveness analysis of palivizumab among pre-term infant populations covered by Medicaid in the United StatesLeonard B Weiner, Anthony S Masaquel, Mark J Polak, et al.
Journal of Medical Economics|May 12, 2012
Cost utility of palivizumab prophylaxis among pre-term infants in the United States: a national policy perspectiveParthiv J Mahadevia, Anthony S Masaquel, Mark J Polak, et al.
Clinical Pediatrics|April 22, 2008
Dipylidium caninum mimicking recurrent enterobius vermicularis (pinworm) infectionAyman Samkari, Deanna L Kiska, Scott W Riddell, et al.
The Journal of Pediatrics|December 17, 2009
Incidence of invasive community-onset Staphylococcus aureus infections in children in Central New YorkManika Suryadevara, Maria R Moro, Paula F Rosenbaum, et al.
BMC Pediatrics|October 14, 2014
Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysisLeonard R Krilov, Anthony S Masaquel, Leonard B Weiner, et al.
Pediatrics|December 2, 2009
The 2009 COID recommendations for RSV prophylaxis: issues of efficacy, cost, and evidence-based medicineLeonard R Krilov, Leonard B Weiner, Ram Yogev, et al.
Vaccine|May 25, 2017
Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infantsNicola P Klein, Remon Abu-Elyazeed, Matthew Cornish, et al.
Pageof 2